NOT AN EXPERIMENT
(www.npr.org)
You're viewing a single comment thread. View all comments, or full comment thread.
Comments (2)
sorted by:
Inside the article it says “ Pfizer also said it was developing a vaccine tailored to combat the omicron variant of the virus — which has spread rapidly around the globe in recent weeks. The company hopes to start clinical trials on the updated omicron-specific vaccine in January.
Pfizer also said 30 million of a planned 80 million treatment courses of its Paxlovid antiviral pill will be available in the first six months of 2022.”